entity

MAC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MAC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

23Hypotheses

0Analyses

1Outgoing

0Incoming

2Experiments

0Debates

No AI portrait yet

Wiki Pages (4)

Knowledge base pages for this entity

Outgoing (1)

Target	Relation	Type	Str
synaptic loss	activates	process	0.70

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (23)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind	0.801	neuroimmunology	TREM2 in Alzheimer's Disease: Mechanisms
Mutant-dependent amplification is context-dependent and stro	0.740	neurodegeneration	Do pathogenic LRRK2 mutations amplify vo
Peripheral Monocyte/Macrophage Infiltration Mimicking Microg	0.710	neuroinflammation	What causes IBA1 low/negative microglia
SNCA Aggregation Hijacks the Endosomal Sorting Complex Requi	0.690	neurodegeneration	-
CCL2-CCR2 Driven Macrophage Infiltration Selectively Strips	0.682	ALS	CCL2-CCR2 Axis at NMJ: Mechanism of Sele

Pharmacological EZH2 Inhibition Resets Polycomb-Mediated Rep	0.680	neurodegeneration	epigenetic reprogramming aging neurons
Pharmacologically Boost AQP4X Readthrough to Restore Perivas	0.650	neurodegeneration	How can AQP4 be effectively targeted the
IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral	0.648	neuroinflammation	How do B cells mechanistically orchestra
C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macropha	0.631	neuroinflammation	What are the specific molecular mechanis
Targeting Synaptic Vesicle Release Machinery to Block Tau Ex	0.630	neuroscience	Trans-synaptic tau spreading and propaga
Pharmacological Enhancement of APOE4 Glycosylation	0.622	neurodegeneration	APOE4 structural biology and therapeutic
M1 Muscarinic Receptor Agonism as Pharmacological Exercise S	0.589	neurodegeneration	What are the specific circulating factor
Pharmacological P2RY12 inhibition (ticagrelor/clopidogrel) a	0.583	neurodegeneration	How does P2RY12-mediated VSMC dysfunctio
MOG-IgG induces spinal cord demyelination through Fcγ recept	0.560	neuroinflammation	What are the specific pathophysiological
CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macr	0.535	neurodegeneration	How do perivascular cells specifically r
Pharmacogenomic CNS Drug Optimization Platform	0.524	neurodegeneration	How do neurodegeneration gene expression
Nuclear Pore and Nucleocytoplasmic Transport Machinery as Ga	0.500	neurodegeneration	What determines the specificity of RNA-p
TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1	0.496	neurodegeneration	How do perivascular cells specifically r
Light-Independent Chronopharmacology	0.455	chronobiology	Can circadian interventions reverse micr
Pharmacologic modulation of D2 autoreceptor-Gi/o signaling i	0.420	neurodegeneration	Does RGS6 upregulation or D2 autorecepto
Exposure profile may matter more than nominal daily dose, bu	0.390	neurodegeneration	-
Amyloidogenic segments undergo conformational templating by	0.380	protein biochemistry	Do chaperones selectively recognize path
Astrocyte-Neuron Lactate Shuttle Enhancement via Pharmacolog	0.308	metabolomics	Metabolomic signatures of neurodegenerat

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (2)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Autophagy receptor identification for stress granule elimination	exploratory	neurodegenerative diseases	0.900	0.00	cultured cells under arsenite	proposed	N/A
IL-10 deficiency and VLC ceramide accumulation in inflammatory bowel d	validation	inflammatory bowel disease	0.900	0.00	IL-10 knockout mice	proposed	N/A

Related Papers (3)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Neurodegeneration and demyelination in multiple sclerosis. [PMID:38889714]	Garton T, Gadani SP, Gill AJ, Calabresi	Neuron	2024
STING orchestrates the neuronal inflammatory stress response in multiple scleros [PMID:38878778]	Woo MS, Mayer C, Binkle-Ladisch L, Sonne	Cell	2024
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. [PMID:36917977]	Neel DV, Basu H, Gunner G, Bergstresser	Neuron	2023

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning MAC in their description or question text

Pharmacological EZH2 Inhibition Resets Polycomb-Mediated Repression of Synaptic

Score: 0.680 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The polycomb repressive complex 2 (PRC2) represents a fundamental epigenetic regu

Pharmacologically Boost AQP4X Readthrough to Restore Perivascular Clearance

Score: 0.650 · neurodegeneration · 2026-04-21

## **Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of the br

IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral Tolerance Through M

Score: 0.648 · neuroinflammation · 2026-04-13

## Mechanistic Overview IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral Tolerance Through Macrophage Reprog

C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macrophages

Score: 0.631 · neuroinflammation · 2026-04-21

**Molecular Mechanism and Rationale** The C1Q complement system component represents a critical bridge between innate i

Targeting Synaptic Vesicle Release Machinery to Block Tau Exocytosis

Score: 0.630 · neuroscience · 2026-04-22

## Mechanistic Overview Targeting Synaptic Vesicle Release Machinery to Block Tau Exocytosis starts from the claim that

Pharmacological Enhancement of APOE4 Glycosylation

Score: 0.622 · neurodegeneration · 2026-04-02

## Mechanistic Overview Pharmacological Enhancement of APOE4 Glycosylation starts from the claim that modulating ST6GAL1

M1 Muscarinic Receptor Agonism as Pharmacological Exercise Substitute

Score: 0.589 · neurodegeneration · 2026-04-14

## Mechanistic Overview M1 Muscarinic Receptor Agonism as Pharmacological Exercise Substitute starts from the claim that

Pharmacological P2RY12 inhibition (ticagrelor/clopidogrel) as repurposing probe

Score: 0.583 · neurodegeneration · 2026-04-21

## **Molecular Mechanism and Rationale** The P2RY12 receptor, a G-protein coupled receptor (GPCR) primarily known for i

MOG-IgG induces spinal cord demyelination through Fcγ receptor-dependent macroph

Score: 0.560 · neuroinflammation · 2026-04-21

## Mechanistic Overview MOG-IgG induces spinal cord demyelination through Fcγ receptor-dependent macrophage activation s

CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering

Score: 0.535 · neurodegeneration · 2026-04-22

## Mechanistic Overview CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering NF-κB-Dependent

Pharmacogenomic CNS Drug Optimization Platform

Score: 0.524 · neurodegeneration · 2026-04-12

## **Molecular Mechanism and Rationale** The pharmacogenomic CNS drug optimization platform leverages fundamental diffe

Nuclear Pore and Nucleocytoplasmic Transport Machinery as Gatekeepers

Score: 0.500 · neurodegeneration · 2026-04-21

## Mechanistic Overview Nuclear Pore and Nucleocytoplasmic Transport Machinery as Gatekeepers starts from the claim that

TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 Upregulation Through

Score: 0.496 · neurodegeneration · 2026-04-22

## Mechanistic Overview TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 Upregulation Through CSF1R-Mediated

Light-Independent Chronopharmacology

Score: 0.455 · chronobiology · 2026-04-27

Small molecules targeting casein kinase 1 to directly entrain peripheral circadian clocks in brain microglia without lig

Pharmacologic modulation of D2 autoreceptor-Gi/o signaling in established PD mod

Score: 0.420 · neurodegeneration · 2026-04-25

Test whether carefully titrated D2-pathway modulation can normalize pathological autoreceptor signaling after alpha-synu

MAC